
Spectrum Pharmaceuticals SPPI
Spectrum Pharmaceuticals Total Shareholders Equity | SPPI
Annual Total Shareholders Equity Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.9 M | 47.6 M | 134 M | 190 M | 271 M | 351 M | 236 M | 213 M | 255 M | 282 M | 289 M | 188 M | 74.5 M | 108 M | 53.1 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 351 M | 27.9 M | 181 M |
Quarterly Total Shareholders Equity Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.8 M | 27.9 M | 35.9 M | 33.4 M | 55.3 M | 47.6 M | 79.5 M | 109 M | 122 M | 134 M | 168 M | 131 M | 154 M | 190 M | 223 M | 243 M | 261 M | 271 M | 287 M | 344 M | 324 M | 351 M | 305 M | 199 M | 217 M | 236 M | 251 M | 236 M | 208 M | 213 M | 215 M | 234 M | 230 M | 255 M | 257 M | 266 M | 266 M | 282 M | 302 M | 278 M | 284 M | 289 M | 280 M | 263 M | 239 M | 188 M | 174 M | 114 M | 188 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 351 M | 26.8 M | 206 M |
Total Shareholders Equity of other stocks in the Biotechnology industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
PTC Therapeutics
PTCT
|
-205 M | $ 56.23 | -3.59 % | $ 4.47 B | ||
|
Pulmatrix
PULM
|
3.59 M | $ 1.24 | -12.34 % | $ 4.53 B | ||
|
InflaRx N.V.
IFRX
|
41.6 M | $ 1.05 | -3.67 % | $ 70.7 M | ||
|
Immunome
IMNM
|
634 M | $ 15.69 | -5.54 % | $ 1.37 B | ||
|
Immuron Limited
IMRN
|
8.07 M | $ 0.9 | 5.87 % | $ 208 M | ||
|
Incyte Corporation
INCY
|
5.17 B | $ 114.5 | -1.19 % | $ 22.4 B | ||
|
INmune Bio
INMB
|
23.5 M | $ 0.82 | -8.41 % | $ 20.3 M | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
337 B | $ 14.88 | 0.24 % | $ 12.4 B | ||
|
Regeneron Pharmaceuticals
REGN
|
31.3 B | $ 920.38 | -0.22 % | $ 96.3 B | ||
|
Ionis Pharmaceuticals
IONS
|
489 M | $ 26.58 | -2.37 % | $ 4.25 B | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
1.93 B | $ 1.06 | -10.92 % | $ 48.4 M | ||
|
Ironwood Pharmaceuticals
IRWD
|
-262 M | $ 4.68 | -0.53 % | $ 757 M | ||
|
Kala Pharmaceuticals
KALA
|
7 M | $ 2.73 | -9.61 % | $ 22.2 M | ||
|
Intellia Therapeutics
NTLA
|
671 M | $ 10.02 | 5.24 % | $ 1.09 B | ||
|
Adagene
ADAG
|
35.3 M | $ 1.8 | -10.56 % | $ 106 M | ||
|
Denali Therapeutics
DNLI
|
1.01 B | $ 18.43 | 1.29 % | $ 3.18 B | ||
|
Pfizer
PFE
|
86.5 B | $ 27.4 | -0.62 % | $ 156 B | ||
|
Amarin Corporation plc
AMRN
|
459 M | $ 10.56 | -6.26 % | $ 4.38 B | ||
|
ImmuCell Corporation
ICCC
|
27.1 M | $ 11.08 | -0.81 % | $ 100 M | ||
|
Editas Medicine
EDIT
|
27.3 M | $ 1.63 | -4.68 % | $ 145 M | ||
|
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
568 M | $ 93.83 | 0.32 % | $ 6.96 B | ||
|
Agios Pharmaceuticals
AGIO
|
1.19 B | $ 27.54 | -4.24 % | $ 1.6 B | ||
|
Royalty Pharma plc
RPRX
|
9.71 B | $ 68.45 | 1.08 % | $ 29.4 B | ||
|
Equillium
EQ
|
28.6 M | $ 1.06 | -5.36 % | $ 60.7 M | ||
|
Black Diamond Therapeutics
BDTX
|
112 M | $ 1.32 | -5.04 % | $ 75.1 M | ||
|
Abeona Therapeutics
ABEO
|
159 M | $ 2.42 | -1.17 % | $ 128 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
1.23 B | $ 17.1 | -2.79 % | $ 2.88 B | ||
|
Atossa Therapeutics
ATOS
|
39.4 M | $ 1.6 | -8.86 % | $ 13.8 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
139 M | $ 112.31 | -3.84 % | $ 7.3 B | ||
|
ADC Therapeutics SA
ADCT
|
-186 M | $ 1.29 | -2.28 % | $ 164 M | ||
|
Harmony Biosciences Holdings
HRMY
|
870 M | $ 32.58 | -1.21 % | $ 1.87 B | ||
|
Ardelyx
ARDX
|
167 M | $ 2.99 | -2.25 % | $ 721 M | ||
|
Akebia Therapeutics
AKBA
|
32.6 M | $ 0.39 | -8.41 % | $ 100 M | ||
|
Alector
ALEC
|
30.6 M | $ 2.34 | 1.52 % | $ 241 M | ||
|
ALX Oncology Holdings
ALXO
|
26 M | $ 1.06 | 3.43 % | $ 56.9 M | ||
|
Amneal Pharmaceuticals
AMRX
|
-70.8 M | $ 21.12 | -1.26 % | $ 6.62 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
76.6 M | $ 4.03 | -1.11 % | $ 772 M | ||
|
Agenus
AGEN
|
-271 M | $ 5.97 | -2.85 % | $ 178 M | ||
|
PolyPid Ltd.
PYPD
|
11 M | $ 6.1 | -6.87 % | $ 99.7 M | ||
|
AbCellera Biologics
ABCL
|
967 M | $ 9.63 | -8.02 % | $ 2.88 B | ||
|
Artelo Biosciences
ARTL
|
-1.27 M | $ 1.35 | -6.9 % | $ 255 K | ||
|
Immatics N.V.
IMTX
|
484 M | $ 5.76 | -3.19 % | $ 705 M | ||
|
Aptevo Therapeutics
APVO
|
17.4 M | $ 0.4 | -2.61 % | $ 126 K | ||
|
Aligos Therapeutics
ALGS
|
53.5 M | $ 1.22 | -2.4 % | $ 12.1 M | ||
|
Aclaris Therapeutics
ACRS
|
103 M | $ 3.44 | -1.86 % | $ 422 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
219 M | $ 27.46 | -2.1 % | $ 4.17 B | ||
|
Cellectar Biosciences
CLRB
|
8.54 M | $ 0.83 | -8.27 % | $ 2.16 M |